VTV THERAPEUTICS INC - CL A (VTVT)

CUSIP: 918385105

Q1 2022 13F Holders as of 31 Mar 2022

Share change
-1,321,344
SEC-reported price per share
$0.72
Number of holders
22
Value change
-$1,271,737
Number of buys
4
Number of sells
16

Security key

918385105

Report period

Q1 2022

Institutions

22

Top holders

10

Ownership snapshot

Top reported holders of VTVT - VTV THERAPEUTICS INC - CL A (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ronald O Perelman
Disclosed value leader
Strengthening Families & ...
Comparable rows
0/15
Latest evidence
03 Mar 2022
3/4/5 13F Highest disclosed value: $51,008,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Strengthening Families & Communities, LLC has the largest disclosed position value at $51.01M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Strengthening Families & Communities, LLC's linked filing trail.
Disclosed position value Top 5
Ronald O Perelman $30.48M
Strengthening Families & Communit... $51.01M
Deepa Prasad $29.51M
Rich S. Nelson $5.9M
VANGUARD GROUP INC $1.75M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ronald O Perelman
3/4/5
10%+ Owner
—
denominator unverified
$30,482,586
36,519,212 shares
— 20 Dec 2021
Strengthening Families & Communities, LLC
13F
Company
13F
—
denominator unverified
$51,008,000
7,142 shares
— 31 Dec 2021
Deepa Prasad
3/4/5
President and CEO, Director
—
denominator unverified
$29,508,879
2,498,635 shares
— 19 Oct 2021
Rich S. Nelson
3/4/5
Acting Chief Executive Officer, Director
—
denominator unverified
$5,905,000
500,000 shares
— 03 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,750,000
1,759,360 shares
— 31 Dec 2021
Samsara BioCapital, LLC
13F
Company
13F
—
denominator unverified
$1,627,000
1,635,509 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
22
Shares
5,212,242
Rows available
22
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
22
Q1 2022 holders
22
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .